Akoya Biosciences

Spatial proteomics (PhenoCycler, PhenoImager) used to map immune cells in tumours; agreed to be acquired by Quanterix (2025).

Multiplex immunofluorescence at scale; clinical partnerships for spatial signatures predicting immunotherapy response.

Headquarters

Marlborough, MA, US

Type

diagnostics · AKYA

Website

Connected

not linked directly; found by shared links